Regional Monitoring EECA
by ECUO PLWH
Regional Monitoring EECA
Showing 1-24 of 24 items.
| # | Country | Source of financing | Manufacturer | Tradename | INN | Form | Price per unit ($) | Units in purchase | Units in package | Price per package ($) | Packages in purchase | Price per purchase ($) | Distributor | Year | Purchase date | Delivery date | Registered | In the list of main (vital) medications | WHO prequalification |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Republic of Latvia | Government | ViiV Healthcare | Ziagen | Abacavir (ABC) | 20mg/ml oral solution 240ml | 66.29 | - | 1 | 66.29 | - | - | 2015 | Not specified | Not specified | Not specified | |||
| 2 | Republic of Belarus | Global Fund | GlaxoSmithKline | Abacavir (ABC) | 20mg/ml oral solution 240ml | 14.99 | 165 | 1 | 14.99 | 165 | 2473.35 | UNDP/UNICEF | 2016 | Yes | No | Not specified | |||
| 3 | Republic of Latvia | Government | Viiv Healthcare UK Limited | Ziagen | Abacavir (ABC) | 20mg/ml oral solution 240ml | 82.62 | 82 | 1 | 82.62 | 82 | 6774.84 | National Health Service (NHC) | 2016 | Not specified | Not specified | Not specified | ||
| 4 | Republic of Poland | Government | ViiV Healthcare | Ziagen | Abacavir (ABC) | 20mg/ml oral solution 240ml | 72.5 | 100 | 1 | 72.5 | 100 | 7250 | 2015 | Not specified | Not specified | Not specified | |||
| 5 | Republic of Uzbekistan | Global Fund | Aurobindo Pharma Ltd. | Abacavir (ABC) | 20mg/ml oral solution 240ml | 12 | - | 1 | 12 | - | - | 2015 | Not specified | Not specified | Not specified | ||||
| 6 | Republic of Poland | Government | GlaxoSmithKline | Ziagen | Abacavir (ABC) | 20mg/ml oral solution 240ml | 69.39 | 50 | 1 | 69.39 | 50 | 3469.5 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 7 | Republic of Kazakhstan | Government | Kievmedpreparat, Ukraine | Abacavir (ABC) | 20mg/ml oral solution 240ml | 119.48 | 596 | 1 | 119.48 | 596 | 71210.08 | 2015 | Not specified | Not specified | Not specified | ||||
| 8 | Georgia | Global Fund | Hetero labs Ltd. | Abacavir (ABC) | 20mg/ml oral solution 240ml | 7.5 | 216 | 1 | 7.5 | 216 | 1620 | partnership for supply. chain management (PFSCM) | 2015 | Not specified | Not specified | Not specified | |||
| 9 | Republic of Moldova | Government | Viiv Healthcare UK Limited | Ziagen | Abacavir (ABC) | 20mg/ml oral solution 240ml | 59.98 | 114 | 1 | 59.98 | 114 | 6837.72 | Dita Estfarm SRL | 2015 | Not specified | Not specified | Not specified | ||
| 10 | Republic of Uzbekistan | Global Fund | Aurobindo Pharma Ltd. | Abacavir | Abacavir (ABC) | 20mg/ml oral solution 240ml | 12 | 1 | 1 | 12 | 1 | 12 | 2016 | Yes | Yes | Yes | |||
| 11 | Republic of Kazakhstan | Government | GlaxoSmithKline | Ziagen | Abacavir (ABC) | 20mg/ml oral solution 240ml | 71.2 | 1 | 1 | 71.2 | 1 | 71.2 | 2016 | Yes | Not specified | Not specified | |||
| 12 | Ukraine | Government | ViiV Healthcare | Abacavir (ABC) | 20mg/ml oral solution 240ml | 0.08 | 1191015 | 1 | 0.08 | 1191015 | 95281.2 | 2015 | Not specified | Not specified | Not specified | ||||
| 13 | Georgia | Global Fund | Aurobindo Pharma Ltd. | Abacavir (ABC) | 20mg/ml oral solution 240ml | 6.83 | 45 | 1 | 6.83 | 45 | 307.35 | partnership for supply. chain management (PFSCM) | 2016 | Yes | Yes | Not specified | |||
| 14 | Russian Federation | Government | GlaxoSmithKline | Ziagen | Abacavir (ABC) | 20mg/ml oral solution 240ml | 36.8 | 659 | 1 | 36.8 | 659 | 24251.2 | 2016 | Yes | Yes | Not specified | |||
| 15 | Republic of Poland | Government | ViiV Healthcare | Ziagen | Abacavir (ABC) | 20mg/ml oral solution 240ml | 72.5 | 44 | 1 | 72.5 | 44 | 3190 | 2015 | Not specified | Not specified | Not specified | |||
| 16 | Republic of Tajikistan | Global Fund | ViiV Healthcare | Abacavir (ABC) | 20mg/ml oral solution 240ml | 8 | - | 1 | 8 | - | - | 2015 | Not specified | Not specified | Not specified | ||||
| 17 | Republic of Poland | Government | GlaxoSmithKline | Ziagen | Abacavir (ABC) | 20mg/ml oral solution 240ml | 69.39 | 100 | 1 | 69.39 | 100 | 6939 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 18 | Republic of Poland | Government | ViiV Healthcare | Ziagen | Abacavir (ABC) | 20mg/ml oral solution 240ml | 72.5 | 40 | 1 | 72.5 | 40 | 2900 | 2015 | Not specified | Not specified | Not specified | |||
| 19 | Republic of Armenia | Global Fund | Aurobindo Pharma Ltd. | Abacavir (ABC) | 20mg/ml oral solution 240ml | 6.75 | 2 | 1 | 6.75 | 2 | 13.5 | VPP, through Partnership for Supply Chain Management (PFSCM) | 2015 | 2015-03-11 | 2015-10-14 | Not specified | Not specified | Not specified | |
| 20 | Republic of Poland | Government | GlaxoSmithKline | Ziagen | Abacavir (ABC) | 20mg/ml oral solution 240ml | 69.39 | 50 | 1 | 69.39 | 50 | 3469.5 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 21 | Russian Federation | Government | ViiV Healthcare | Ziagen | Abacavir (ABC) | 20mg/ml oral solution 240ml | 45.6 | 21875 | 1 | 45.6 | 21875 | 997500 | 2015 | Not specified | Not specified | Not specified | |||
| 22 | Republiс of Azerbaijan | Government | Aurobindo Pharma Ltd. | Abacavir (ABC) | 20mg/ml oral solution 240ml | 37.44 | 533 | 1 | 37.44 | 533 | 19955.52 | 2015 | Yes | Yes | Not specified | ||||
| 23 | Republic of Tajikistan | Global Fund | Aurobindo Pharma Ltd. | Abacavir (ABC) | 20mg/ml oral solution 240ml | 10.5 | 1044 | 1 | 10.5 | 1044 | 10962 | UNDP/UNICEF | 2016 | Not specified | Yes | Not specified | |||
| 24 | Ukraine | Government | Hetero labs Ltd. | Abacavir | Abacavir (ABC) | 20mg/ml oral solution 240ml | 9.15 | 4963 | 1 | 9.15 | 4963 | 45411.45 | 2016 | Yes | Yes | Yes |